Peter D Kwong Selected Research

Peter D Kwong Research Topics

Disease

82	Infections 02/2024 - 03/2003
26	COVID-19 02/2024 - 01/2020
13	Human Influenza (Influenza) 01/2023 - 06/2009
10	Malaria 01/2023 - 01/2018
6	Virus Diseases (Viral Diseases) 03/2021 - 05/2013
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 05/2005
5	Pneumonia (Pneumonitis) 02/2021 - 07/2015
4	Viremia 01/2023 - 09/2015
3	Communicable Diseases (Infectious Diseases) 01/2023 - 07/2015
3	Respiratory Syncytial Virus Infections 01/2023 - 02/2010
2	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2019
2	Severe Acute Respiratory Syndrome 02/2021 - 01/2020
2	Edema (Dropsy) 02/2021 - 01/2021
2	Bronchiolitis 01/2020 - 11/2016
2	Paramyxoviridae Infections (Parainfluenza) 11/2018 - 11/2016
2	Neoplasms (Cancer) 10/2017 - 01/2017
2	Persistent Infection 11/2015 - 01/2015
2	HIV Infections (HIV Infection) 06/2015 - 10/2007
2	Gastroenteritis 01/2012 - 07/2011
1	Influenza in Birds (Avian Flu) 11/2023
1	Coronavirus Infections 01/2022
1	Inflammation (Inflammations) 10/2020
1	Myalgia 10/2019
1	Chills 10/2019
1	Headache (Headaches) 10/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 11/2018
1	Hepatitis B 11/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017
1	Breakthrough Infections 02/2015
1	Vesicular Stomatitis 01/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2011

Drug/Important Bio-Agent (IBA)

49	VaccinesIBA 02/2024 - 05/2005
42	AntibodiesIBA 02/2024 - 05/2005
20	Neutralizing AntibodiesIBA 01/2023 - 03/2003
19	Broadly Neutralizing AntibodiesIBA 01/2024 - 01/2012
19	EpitopesIBA 01/2023 - 05/2005
14	Glycoproteins (Glycoprotein)IBA 10/2019 - 07/2003
13	Monoclonal AntibodiesIBA 01/2023 - 05/2005
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2012
9	Antiviral Agents (Antivirals)IBA 06/2023 - 11/2008
8	Hemagglutinins (Hemagglutinin)IBA 01/2023 - 09/2015
5	AntigensIBA 10/2020 - 06/2009
3	mRNA VaccinesIBA 11/2023 - 08/2022
3	Messenger RNA (mRNA)IBA 08/2023 - 08/2022
3	Peptides (Polypeptides)IBA 01/2023 - 01/2018
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2012
3	Fc Receptors (Fc Receptor)IBA 02/2021 - 09/2015
3	Polysaccharides (Glycans)IBA 01/2020 - 11/2016
3	CD4 Antigens (CD4 Antigen)IBA 01/2019 - 10/2007
2	Ferritins (Ferritin)IBA 01/2023 - 11/2018
2	DH1047IBA 01/2022 - 04/2021
2	Single-Domain AntibodiesIBA 03/2021 - 01/2021
2	CytokinesIBA 02/2021 - 01/2021
2	Blocking AntibodiesIBA 02/2021 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 09/2015
2	peptide AIBA 01/2018 - 01/2018
2	Influenza Vaccines (Influenza Vaccine)FDA Link 07/2017 - 09/2015
2	env Gene ProductsIBA 01/2016 - 01/2012
2	recombinant soluble CD4IBA 09/2009 - 05/2005
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Neuraminidase (Sialidase)IBA 11/2023
1	COVID-19 VaccinesIBA 08/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2023
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 12/2021
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 03/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2020
1	avian influenza A virus hemagglutininIBA 01/2019
1	Hepatitis B Core AntigensIBA 11/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	NBD-11021IBA 01/2017
1	InterferonsIBA 01/2017
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2017
1	LectinsIBA 01/2017
1	Combined VaccinesIBA 12/2016
1	Indicators and Reagents (Reagents)IBA 04/2015
1	Cell Surface ReceptorsIBA 07/2014
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 05/2014
1	Tyrosine (L-Tyrosine)FDA Link 05/2014
1	Blood Group Antigens (Blood Groups)IBA 07/2011
1	Palivizumab FDA Link 02/2010
1	motavizumab (Numax)IBA 02/2010
1	N- (4- chlorophenyl)- N'- (2,2,6,6- tetramethylpiperidin- 4- yl)oxalamideIBA 11/2008
1	ChemokinesIBA 05/2005

Therapy/Procedure

5	Therapeutics 02/2021 - 11/2011
2	Intravenous Administration 01/2022 - 10/2019
1	Immunotherapy 01/2021
1	Liver Transplantation 11/2018
1	Highly Active Antiretroviral Therapy (HAART) 10/2015
1	Aftercare (After-Treatment) 08/2015